Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Favorable safety and tolerability profile in phase 1b and 2 trials (mainly mild/moderate GI events) 1
The control group exhibits the highest neuron density, representing the baseline levels expected in healthy conditions
Every step we take involves feedback from the ground, adjustments around the ankle, knee, hip, trunk, and spine, and constant small stabilizing reactions from the nervous system
The October 1, 2025 release applies to services through March 31, 2026
Milk: 1 cup (250 ml) provides 57% of the DV (22,29)
US$ 26.09
US$ 25.75
US$ 20.19
US$ 24.76
US$ 20.54
US$ 21.01
